Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01057810
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Ipilimumab;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.